MNK, mTOR or eIF4E-selecting the best anti-tumor target for blocking translation initiation
Article in European Journal of Medicinal Chemistry (September 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling
Article in Medical Science Monitor (August 2020)
Blockage of PI3K/mTOR Pathways Inhibits Laser-Induced Choroidal Neovascularization and Improves Outcomes Relative to VEGF-A Suppression AlonePI3K Blocker Inhibits CNV Better Than Aflibercept
Article in Investigative Ophthalmology & Visual Science (June 2016)